DrugAbuse completes naltrexone depot Phase III

DrugAbuse Sciences (Los Altos, Calif.) completed enrollment of more than 300 patients in a double-blind, placebo-controlled U.S. Phase III study of its naltrexone depot to treat alcohol dependence. ...